Corporate Controller - Soleno

Company
- Management
- Board
- Advisors
- Careers
Product Candidate
For Patients
- Prader-Willi Syndrome
- Patient Access
Investors
Contact us

Developing novel therapeutics for the treatment of rare diseases.

Pages

Company
- Management
- Boards
- Advisors
- Careers
For Patients
- Prader-Willi Syndrome
Investors
Contact us

News and Events

Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2022 Financial Results

Soleno Therapeutics Announces Initiation of Randomized Withdrawal Study of DCCR for the Treatment of Prader-Willi Syndrome

Contact Us

203 Redwood Shores Parkway
Suite 500
Redwood City, CA 94065

Tel: (650) 213-8444
Email: info@soleno.life
Find us on Facebook

Soleno Therapeutics, Inc. © 2022 | All Rights Reserved

Terms of Use
Privacy Statement